vaccine

Euronews

Small Phase 1 Safety Trial Tests First AI-Designed Coronavirus Vaccine Candidate

A Phase 1 safety study of an AI-designed protein vaccine against multiple coronaviruses enrolled 39 volunteers and reported no significant safety issues. A Phase 2 trial is now planned.

SK

3 sources